Skip to main content

Peer Review reports

From: Delaying anti-VEGF therapy during the COVID-19 pandemic: long-term impact on visual outcomes in patients with neovascular age-related macular degeneration

Original Submission
21 Nov 2021 Submitted Original manuscript
13 Jan 2022 Reviewed Reviewer Report
24 Feb 2022 Reviewed Reviewer Report - Srinivasan Sanjay
27 Aug 2022 Author responded Author comments - Francesco Viola
Resubmission - Version 2
27 Aug 2022 Submitted Manuscript version 2
30 Aug 2022 Author responded Author comments - Francesco Viola
Resubmission - Version 3
30 Aug 2022 Submitted Manuscript version 3
10 Oct 2022 Reviewed Reviewer Report
11 Nov 2022 Author responded Author comments - Francesco Viola
Resubmission - Version 4
11 Nov 2022 Submitted Manuscript version 4
11 Nov 2022 Author responded Author comments - Francesco Viola
Resubmission - Version 5
11 Nov 2022 Submitted Manuscript version 5
26 Nov 2022 Reviewed Reviewer Report - Srinivasan Sanjay
28 Nov 2022 Reviewed Reviewer Report
11 Dec 2022 Reviewed Reviewer Report - María De La Asunción Pino Vázquez
20 Feb 2023 Author responded Author comments - Francesco Viola
Resubmission - Version 6
20 Feb 2023 Submitted Manuscript version 6
25 Feb 2023 Author responded Author comments - Francesco Viola
Resubmission - Version 7
25 Feb 2023 Submitted Manuscript version 7
25 Feb 2023 Author responded Author comments - Francesco Viola
Resubmission - Version 8
25 Feb 2023 Submitted Manuscript version 8
27 Feb 2023 Author responded Author comments - Francesco Viola
Resubmission - Version 9
27 Feb 2023 Submitted Manuscript version 9
Publishing
17 Mar 2023 Editorially accepted
17 Apr 2023 Article published 10.1186/s12886-023-02864-x

You can find further information about peer review here.

Back to article page